| Abstrakt: |
In those with baseline SBP 170 mm Hg, tranexamic acid reduced haematoma expansion (OR 0.62, 95% CI 0.47 to 0.82, p=0.001), but not in those with baseline SBP>170 mm Hg (OR 1.02, 95% CI 0.77 to 1.35, p=0.90)." Keywords: Blood Pressure; Clinical Research; Clinical Trials and Studies; Cyclohexanecarboxylic Acids; Diagnostics and Screening; Health and Medicine; Neurology; Systolic Blood Pressure; Tranexamic Acid EN Blood Pressure Clinical Research Clinical Trials and Studies Cyclohexanecarboxylic Acids Diagnostics and Screening Health and Medicine Neurology Systolic Blood Pressure Tranexamic Acid 1113 1113 1 06/26/23 20230626 NES 230626 2023 JUN 26 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators publish new report on neurology. [Extracted from the article] |
